Success Stories: Within 2 Months and 5 Days, NIW Case was Approved for a Research and Development Scientist in Polymer Science Hailing from China, Thanks to NAILG’S Team

Posted by wegreened on April 17, 2023 in NIW, Materials Engineering (Textile Technology, Materials Science, Polymer Science)

Client’s Testimonial:

“Thank you again for your professional work so far. Thank you!”

On February 10^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Research and Development Scientist in the Field of Polymer Science (Approval Notice).

General Field: Polymer Science

Position at the Time of Case Filing: Research and Development Scientist

Country of Origin: China

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: February 10^th, 2023

Processing Time: 2 months, 5 days

Case Summary:

The following is the list of items our team used to write a winning National Interest Waiver petition for a Chinese research and development scientist working in polymer science:

As an expert in the area, his endeavor is to work on advancing the exploitation of molecular dynamics in polymer materials to develop sustainable advanced materials and novel polymer science techniques in order to solve global sustainability problems.
His research is of great importance because it provides improved materials for cancer treatment, clean energy technology, and sustainable alternatives to plastics, cancer being one of the world’s leading causes of death, responsible for nearly 10 million deaths in 2020.
His proposed endeavor also has broad implications for the United States where cancer is the second leading cause of death, causing more than 600,000 deaths in 2019.
Due to its clear national importance, his research has also been supported with funding from the American Chemical Society Petroleum Research Fund, the National Science Foundation, and the U.S. Department of Energy.
And he had obtained 4 letters of support from other experts who knew his work, one of whom said:

“[The client’s] work indirectly boosts the American economy by facilitating American medical companies and research organizations to become global leaders in nano vehicle drug delivery techniques. In 2020, the American pharmaceutical industry earned $425 billion in annual revenue and currently makes up almost 48% of the global pharmaceutical market in sales. Given these numbers, it is obvious that [the client’s] research plays a critical role in the United States. Secondly, effective and efficient drug delivery techniques are extremely beneficial for medical treatments, including cancer. Therefore, [the client’s] work also helps improve the healthcare and social security of our country.”

Academically too he had taken great strides and published 9 peer-reviewed journal articles (4 of them first-authored) which had been cited at least 104 times all over the world.
Finally, we also said that he has pursued research directly related to his proposed endeavor for 6 years which has given him immense expertise in the area.

These factors played in his favor and won him the NIW approval in just 2 months and 5 days. We are glad to have assisted him in the application process and we wish him all the best for his future.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%